<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">9866744</article-id><article-id pub-id-type="pmc">2640249</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Introduction of HIV-2 and multiple HIV-1 subtypes to Lebanon.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pieniazek</surname><given-names>D.</given-names></name><email>dxp1@cdc.gov</email></contrib><contrib contrib-type="author"><name><surname>Baggs</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>D. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Matar</surname><given-names>G. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Abdelnoor</surname><given-names>A. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mokhbat</surname><given-names>J. E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Uwaydah</surname><given-names>M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bizri</surname><given-names>A. R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ramos</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Janini</surname><given-names>L. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tanuri</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fridlund</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schable</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heyndrickx</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rayfield</surname><given-names>M. A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heneine</surname><given-names>W.</given-names></name></contrib></contrib-group><aff>HIV/Retrovirus Diseases Branch, Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.</aff><pub-date pub-type="ppub"><season>Oct-Dec</season><year>1998</year></pub-date><volume>4</volume><issue>4</issue><fpage>649</fpage><lpage>656</lpage><abstract><p>HIV genetic variability, phylogenetic relationships, and transmission dynamics were analyzed in 26 HIV-infected patients from Lebanon. Twenty-five specimens were identified as HIV-1 and one as HIV-2 subtype B. The 25 strains were classified into six env-C2-V3 HIV-1 subtypes: B (n = 10), A (n = 11), C (n = 1), D (n = 1), G (n = 1), and unclassifiable. Potential recombinants combining parts of viral regions from different subtypes Aenv/Dpol/Agag, Genv/Apol, and the unclassifiable-subtype(env)/unclassifiable-subtype(pol)/Agag were found in three patients. Epidemiologic analysis of travel histories and behavioral risks indicated that HIV-1 and HIV-2 subtypes reflected HIV strains prevalent in countries visited by patients or their sex partners. Spread of complex HIV-subtype distribution patterns to regions where HIV is not endemic may be more common than previously thought. Blood screening for both HIV-1 and HIV-2 in Lebanon is recommended to protect the blood supply. HIV subtype data provide information for vaccine development.</p></abstract></article-meta></front></article>